$PCSA
Processa Pharmaceuticals, Inc. Common
XNAS•Health Care•Pharmaceutical Preparations
$1.86
▼-1.59%-$0.030
Processa Pharmaceuticals, Inc. Common
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.60 at 09:43 AM on Oct 12, then ran to $1.98 +24% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is PCSA up today? It is at $1.86 (+0.00%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PCSA spikes, and full due diligence on PCSA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PCSA 17 times in the last 30 days. Create a free account to track $PCSA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PCSA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PCSA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystProcessa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics, from an SEC filing. Read it →We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ng George K Officer | Other | 2K 0.06% of company | added 10% | 17K | n/a | Aug 8, 26 |
Ng George K Officer | Bought (open market) | +3K 0.1% of company | added 25% | 15K | $6K at $1.93 | Jul 1, 26 |
Young David Officer | Bought (open market) | +3K 0.09% of company | added 13% | 22K | $5K at $1.93 | Jun 30, 26 |
Skibsted Russell Officer | Bought (open market) | +3K 0.1% of company | added 24% | 17K | $6K at $1.93 | Jun 30, 26 |
Lin Patrick Officer | Bought (open market) | +2K 0.08% of company | added 19% | 13K | $4K at $1.93 | Jun 30, 26 |
Guy Wendy Officer | Bought (open market) | +2K 0.09% of company | added 20% | 14K | $5K at $1.93 | Jun 30, 26 |
Baluch Khoso Director | Other | 203 | added 8.7% | 3K | n/a | Jun 26, 26 |
Neal James R Director | Other | 203 | added 25% | 1K | n/a | Jun 26, 26 |
Pannu Geraldine Director | Other | 203 | added 9.3% | 2K | n/a | Jun 26, 26 |
Yorke Justin W Director | Other | 203 | added 100% | 353 | n/a | Jun 26, 26 |
Guy Wendy Officer | Bought (open market) | +2K 0.08% of company | added 22% | 12K | $5K at $2.22 | Jun 15, 26 |
Lin Patrick Officer | Bought (open market) | +2K 0.07% of company | added 20% | 11K | $4K at $2.22 | Jun 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PCSA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PCSA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PCSA last traded at $1.86, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Processa Pharmaceuticals, Inc. Common (PCSA) is next expected to report earnings on Thursday, November 5, 2026, about 3 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PCSA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PCSA 17 times in the last 30 days.
PCSA (Processa Pharmaceuticals, Inc. Common) trades on XNAS, with a market cap of about $5M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PCSA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PCSA discussion
Sign in to ask a question or join the discussion.